Skip to main content
. 2013 Sep 25;49(8):1253–1263. doi: 10.1007/s00535-013-0884-0

Fig. 2.

Fig. 2

The IFN dose until 24 weeks according to platelet count. The actual IFN dose rate until 24 weeks was evaluated as less than 50, 50–80, and 80 % of the normal dose. Group A, chronic hepatitis (plt ≥8); group B, chronic hepatitis (plt <8); group C, untreated cirrhosis group (plt ≥8); group D, untreated cirrhosis group (plt <8); group E, splenectomy/PSE